Benzolsulfonamid
BSA · BENZENESULPHONAMIDE · CL160 · mandb7973 · benzsulfamide · Benzenesulfomide · Benzosuifqnamide · Benzosulfonamide

Identifikatoren & physikalische Daten
| CAS No. | 98-10-2 |
|---|---|
| Summenformel | C6H7NO2S |
| Durchschnittliche Molmasse | 157,19 g/mol |
| Monoisotopische Masse | 157,01974946 g/mol |
| SMILES | NS(=O)(=O)c1ccccc1 |
| InChIKey | KHBQMWCZKVMBLN-UHFFFAOYSA-N |
| PubChem CID | 7370 |
| ChEMBL | CHEMBL27601 |
| ChEBI | CHEBI:191017 |
| EC No. | 202-637-1 |
| DTXSID | DTXSID1059159 |
| Lokaler Name | Benzolsulfonamid |
Chemische & physikalische Eigenschaften
| XLogP | 0,3 |
|---|---|
| Polarare Oberfläche (TPSA) | 68,5 |
| H-Brücken-Donoren | 1 |
| H-Brücken-Akzeptoren | 3 |
| Frei drehbare Bindungen | 1 |
| Schwere Atome | 10 |
| Formalladung | 0 |
| Komplexität | 186 |
| Stoffklassen | Nitrogen Compounds -> Sulfonamides |
| Pestizide | Environmental transformation -> Pesticide transformation products (metabolite, successor) |
| Dampfdruck | 0.000894 [mmHg] |
| Physical Description | White to cream odorless crystalline powder[Alfa Aesar MSDS] |
| Schmelzpunkt | 149-152 °C (lit.) |
| Siedepunkt | 315.5±25.0 °C(Predicted) |
| Dichte | 1.274 (estimate) |
| Brechungsindex | 1.5500 (estimate) |
| Flammpunkt | 250°C |
| Lagerbedingungen | Store below +30°C. |
| Löslichkeit | methanol: soluble25mg/mL4.3 g/L (16 ºC) |
| pKa (Säurekonstante) | 10.1(at 25℃) |
| Aggregatzustand | Powder, Crystals and/or Chunks |
| Farbe | White to off-white |
| BRN | 1100566 |
| InChI | 1S/C6H7NO2S/c7-10(8,9)6-4-2-1-3-5-6/h1-5H,(H2,7,8,9) |
| InChIKey | KHBQMWCZKVMBLN-UHFFFAOYSA-N |
| SMILES | NS(=O)(=O)c1ccccc1 |
| CAS Datenbank | 98-10-2(CAS DataBase Reference) |
| NIST chemische Informationen | Benzenesulfonamide(98-10-2) |
| EPA chemische Informationen | Benzenesulfonamide (98-10-2) |
Sicherheit & Vorschriften
| GHS-Einstufung | WarningH302 (100%): Harmful if swallowed [Warning Acute toxicity, oral]P264, P270, P301+P317, P330, and P501 (click each P-code to see the statement)Aggregated GHS information provided per 167 reports by companies from 4 notifications to the ECHA C&L Inventory.DangerH372: Causes damage to organs through prolonged or repeated exposure [Danger Specific target organ toxicity, repeated exposure] |
|---|---|
| Regulatorische Informationen | Chemical: BenzenesulfonamideStatus: Active Update: 08-09-2021 https://echa.europa.eu/registration-dossier/-/registered-dossier/32759Benzenesulphonamide: Does not have an individual approval but may be used under an appropriate group standard |
| Gefahrenübersicht | Causes liver function test abnormalities, changes in leukocyte and erythrocyte counts, and weight loss in repeated-dose oral studies of rats[RTECS] May cause irritationHarmful by ingestion[Alfa Aesar MSDS] See N-Butylbenzenesulfonamide. See Sulfanilamide. |
| Hazard Classes and Categories | Acute Tox. 4 (100%)Specific target organ toxicity - Repeated exposure - Category 1 (urinary bladder), Category 2 (liver, kidney, lung) |
| Unerwünschte Wirkungen | Occupational hepatotoxin - Secondary hepatotoxins: the potential for toxic effect in the occupational setting is based on cases of poisoning by human ingestion or animal experimentation. |
| Wassergefährdungsklasse (WGK) | 3 |
| TSCA-Inventar-Status | TSCA listed |
| Zollcode | 29350090 |
| RTECS-Nr. | DA9380000 |
| R-Sätze (R) | 22 |
| Toxizität | LD50 orally in Rabbit: 991 mg/kg |
| Gefahrensymbole | Xn |
| Sicherheitshinweise (S) | 36 |
| Lagerklasse | 11 - Combustible Solids |
| Gefahrenklasse | Acute Tox. 4 Oral |
Anwendungen & Verwendung
Verwenden
Biospecific adsorption of carbonic anhydrase to self-assembled monolayers of alkanethiolates that present benzenesulfonamide groups on gold. Biospecific binding of carbonic anhydrase to mixed sams presenting benzenesulfonamide ligands led to a model system for studying lateral steric effects. Benzenesulfonamide modifications at c-7 of ciprofloxacin change its primary target instreptococcus pneumoniae from topoisomerase iv to gyrase. Polar substitutions in the benzenesulfonamide ring of celecoxib afford a potent 1,5-diarylpyrazole class of COX-2 inhibitors.
Herstellung & Synthese
synthetische
Benzenesulfonamide is obtained by amination of benzenesulfonyl chloride.